Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11297810 Animal models and therapeutic molecules
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Current Assignee
Kymab
Date Filed
March 7, 2019
Date of Patent
April 12, 2022
Patent Applicant
Kymab
Patent Application Number
16296033
Patent Citations
US Patent 10251377 Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
US Patent 10605808 Antibody producing non-human animals
US Patent 10667501 Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulins
US Patent 10730930 Antibodies, variable domains and chains tailored for human use
US Patent 10966412 Animal models and therapeutic molecules
US Patent 10774155 Animal models and therapeutic molecules
US Patent 11051497 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US Patent 10064398 Animal models and therapeutic molecules
US Patent 10149462 Animal models and therapeutic molecules
US Patent 10165763 Animal models and therapeutic molecules
•••
Patent Citations Received
US Patent 11707056 Animals, repertoires and methods
0
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11297810
Patent Primary Examiner
Shin-Lin Chen
CPC Code
A01K 2227/105
A01K 2267/01
C12N 15/8509
C12N 2517/02
A01K 2207/15
A01K 67/0278
Find more entities like US Patent 11297810 Animal models and therapeutic molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE